Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) just unveiled an announcement.
Charmacy Pharmaceutical Co., Ltd. has announced a proposal to abolish its Board of Supervisors, subject to shareholder approval at an extraordinary general meeting. The functions of the Board of Supervisors will be assumed by the Audit Committee of the Board of Directors, aiming to improve corporate governance and operational standards. Additionally, the company plans to amend its Articles of Association to align with these changes, which are expected to enhance compliance with legal and regulatory requirements.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company established in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products and services, with a market presence in the PRC.
Average Trading Volume: 47,613
Technical Sentiment Signal: Sell
Current Market Cap: HK$584.3M
See more data about 2289 stock on TipRanks’ Stock Analysis page.